A commonly calculated subcomponent is the FACT-Trial Outcome Index (TOI ... followed by randomization with or without adjuvant durvalumab. In a secondary analysis of PROs from PACIFIC, Hui et al 26 ...
However the results of the phase III MYSTIC trial were not a huge surprise, as the combination of Imfinzi (durvalumab), a PD ... based on the phase III PACIFIC trial. In the US it is also approved ...
In January, the company announced positive results from a phase 1b/2a trial of amycretin ... operate 64 plants at customer sites. Canadian Pacific Kansas City Limited (NYSE:CP) owns and operates ...
Top-line results from the ADRIATIC trial reported this morning show that Imfinzi (durvalumab ... inoperable or unresected stage I-II NSCLC in PACIFIC-4, and unresectable, stage III NSCLC in ...
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
David Spigel, MD, discusses the findings from and methodology behind the ADRIATIC study of durvalumab as consolidation therapy for patients with limited-stage small cell lung cancer.
WILMINGTON, Del.--(BUSINESS WIRE)--Results from a post-hoc exploratory subgroup analysis from the NIAGARA Phase III trial showed AstraZeneca’s IMFINZI ® (durvalumab), administered ...
SEATTLE — Hikers on the Pacific Crest Trail will now have to take a detour on their way to Canada. The change goes into effect on Friday. The Canada Border Services Agency announced that hikers ...
Planning a 2,650-mile trek on the Pacific Crest Trail from the U.S.-Mexico border to Canada? Prepare to turn around. On Monday, the Canada Border Services Agency announced it will no longer issue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback